Cargando…

Sustainable Drug Delivery of Famotidine Using Chitosan‐Functionalized Graphene Oxide as Nanocarrier

This work mainly focuses on the graphene oxide (GO)‐assisted sustainable drug delivery of famotidine (FMT) drug. Famotidine is loaded onto GO and encapsulated by chitosan (CH). UV‐visible spectroscopy, field emission scan electron microscopy, and atomic force microscopy confirm the loading of FMT on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahajan, Chetan Ramesh, Joshi, Lalit B., Varma, Umakant, Naik, Jitendra B., Chaudhari, Vijay Raman, Mishra, Satyendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777207/ https://www.ncbi.nlm.nih.gov/pubmed/31592120 http://dx.doi.org/10.1002/gch2.201900002

Ejemplares similares

Nanogels as nanocarriers for drug delivery: A review
por: Rajput, Rahul, et al.
Publicado: (2019)

A porous reduced graphene oxide/chitosan-based nanocarrier as a delivery system of doxorubicin
por: Hazhir, N., et al.
Publicado: (2019)

A pH-sensitive nanocarrier based on BSA-stabilized graphene-chitosan nanocomposite for sustained and prolonged release of anticancer agents
por: Gooneh-Farahani, Sahar, et al.
Publicado: (2021)

Montmorillonite-Famotidine/Chitosan Bio-nanocomposite Hydrogels as a Mucoadhesive/Gastroretentive Drug Delivery System
por: Farhadnejad, Hassan, et al.
Publicado: (2022)

Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021)

Formulation and Evaluation of Floating Drug Delivery System of Famotidine
por: Satishbabu, B. K., et al.
Publicado: (2010)

What Underlies the Benefit of Famotidine Formulations Used During COVID-19?
por: Singh, Vijay P., et al.
Publicado: (2021)

Famotidine induced hypomagnesemia leading to hypocalcemia
por: Essrani, Rajesh, et al.
Publicado: (2020)

Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)

A method for improving the properties of famotidine
por: Zhao, Yongfeng, et al.
Publicado: (2023)

Chitosan Based MicroRNA Nanocarriers
por: Genedy, Hussein H., et al.
Publicado: (2022)

Functionalized Graphene Oxide with Chitosan for Protein Nanocarriers to Protect against Enzymatic Cleavage and Retain Collagenase Activity
por: Emadi, Fatemeh, et al.
Publicado: (2017)

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
por: Upreti, Vijay V, et al.
Publicado: (2013)

Hepatitis following famotidine: a case report
por: Gupta, Nishant, et al.
Publicado: (2009)

Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
por: Larsen, Timothy R., et al.
Publicado: (2018)

Pharmacokinetics and efficacy of intravenous famotidine in adult cattle
por: Balcomb, Christie C., et al.
Publicado: (2018)

Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization
por: Gaglio, Salvatore Calogero, et al.
Publicado: (2023)

Add Sugar to Chitosan: Mucoadhesion and In Vitro Intestinal Permeability of Mannosylated Chitosan Nanocarriers
por: Ejaz, Sadaf, et al.
Publicado: (2022)

Development and evaluation of novel-trans-buccoadhesive films of Famotidine
por: Alagusundaram, M., et al.
Publicado: (2011)

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
por: Malone, Robert W., et al.
Publicado: (2020)

Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19
por: Alper, Kenneth
Publicado: (2020)

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
por: Malone, Robert W., et al.
Publicado: (2021)

Stimuli-responsive chitosan-based nanocarriers for cancer therapy
por: Fathi, Marziyeh, et al.
Publicado: (2017)

Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers
por: Caprifico, Anna E., et al.
Publicado: (2020)

The Role of Graphene Oxide Nanocarriers in Treating Gliomas
por: Wang, Bin, et al.
Publicado: (2022)

Nanocarriers for ocular drug delivery: Recent advances and future opportunities
por: Amrutkar, Chetan S, et al.
Publicado: (2023)

Formulation development and in vitro evaluation of gastroretentive hollow microspheres of famotidine
por: Chordiya, Mayur A, et al.
Publicado: (2011)

Serum Concentrations of Gastrin after Famotidine and Omeprazole Administration to Dogs
por: Parente, N.L., et al.
Publicado: (2014)

Effect of Famotidine on COVID-19: Killing Virus or Opposing ARDS?
por: Hosseini, Mahnaz Sadat, et al.
Publicado: (2023)

A Chitosan-Based Micellar System as Nanocarrier For the Delivery of Paclitaxel
por: Han, Yang, et al.
Publicado: (2020)

Designing of the Anticancer Nanocomposite with Sustained Release Properties by Using Graphene Oxide Nanocarrier with Phenethyl Isothiocyanate as Anticancer Agent
por: Jaya Seema, Dasan Mary, et al.
Publicado: (2018)

Utility of N-Bromosuccinimide for the Titrimetric and Spectrophotometric Determination of Famotidine in Pharmaceutical Formulations
por: Zenita, O., et al.
Publicado: (2011)

Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine
por: Patel, Dasharath M, et al.
Publicado: (2011)

Novel swellable polymer of orchidaceae family for gastroretentive drug delivery of famotidine
por: Razavi, Mahboubeh, et al.
Publicado: (2014)

Tizanidine-induced acute severe cystitis in a female taking famotidine
por: Poudel, Resham Raj, et al.
Publicado: (2015)

Famotidine Against SARS-CoV2: A Hope or Hype?
por: Ghosh, Ritwik, et al.
Publicado: (2020)

The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
por: Loffredo, Madeline, et al.
Publicado: (2021)

Famotidine promotes inflammation by triggering cell pyroptosis in gastric cancer cells
por: Huang, Jin, et al.
Publicado: (2021)

Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm
por: yang, huan, et al.
Publicado: (2022)

Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm
por: Yang, Huan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6148cstutvoepe556nqjicj515